Bdfucil 100mg/224mg Capsule

About

Bdfucil 100mg/224mg Capsule is a fixed-dose combination medication designed to address complex respiratory tract infections, particularly those involving bacterial pathogens and excessive mucus production. It combines an antibacterial agent (100mg) with a mucolytic or expectorant component (224mg). The antibacterial component targets susceptible bacteria responsible for respiratory infections, inhibiting their growth or directly killing them, thereby resolving the underlying infection. The mucolytic/expectorant component works by thinning and loosening tenacious mucus in the airways, facilitating its clearance and improving respiratory function.

This dual-action approach provides comprehensive relief by treating the infection and alleviating associated symptoms like cough and congestion. The medication is absorbed orally, with both components undergoing metabolism and excretion through various pathways. It is crucial to complete the full course of therapy to ensure complete eradication of the infection and prevent the development of antibiotic resistance. Patients should be advised on proper hydration to aid the mucolytic effect and to report any persistent or worsening symptoms.

Uses

• Treatment of acute and chronic bronchitis with bacterial infection.
• Management of sinusitis complicated by bacterial infection and congestion.
• Relief of symptoms associated with pneumonia with excessive mucus.
• Adjunctive therapy for respiratory infections requiring both antibacterial and mucolytic action.

Directions For Use

Take one capsule orally twice daily with food. Ensure adequate hydration to enhance the mucolytic effect.

Benefits

• Dual action: treats infection and clears mucus.
• Broad-spectrum antibacterial coverage.
• Facilitates easier breathing.
• Reduces cough severity.
• Convenient fixed-dose combination.
• Aids in faster recovery from respiratory infections.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Stomach upset
• Headache
• Dizziness
• Skin rash
• Allergic reactions
• Taste disturbance
• Dry mouth
• Insomnia
• Superinfection (e.g., fungal)

Safety Measures

• Alcohol - Alcohol consumption should be limited or avoided during Bdfucil treatment, as it may exacerbate gastrointestinal side effects or interact with the antibacterial component, potentially reducing efficacy or increasing toxicity.
• Pregnancy - The safety of Bdfucil during pregnancy has not been established. It should only be used if the potential benefit outweighs the potential risks to the fetus, and under strict medical guidance.
• Breastfeeding - Components of Bdfucil may be excreted into breast milk. Due to potential risks to the nursing infant, breastfeeding is generally not recommended during treatment. Consult a healthcare professional.
• Liver - Patients with pre-existing liver impairment should use Bdfucil with caution, as both components may undergo hepatic metabolism. Monitoring of liver function tests may be necessary.
• Kidney - Dose adjustments may be required for patients with significant renal impairment, particularly for the antibacterial component, which may be renally excreted. Close monitoring of kidney function is advised.
• Lung - Bdfucil is indicated for lung conditions. However, caution is advised in patients with severe asthma or chronic obstructive pulmonary disease (COPD) with impaired cough reflex, as excessive mucus mobilization could pose a risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.